![Jean-Pierre Bouiller](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jean-Pierre Bouiller
Miembro del Comité de Inversión en Sofimac Régions SAS .
Cargos activos de Jean-Pierre Bouiller
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Sofimac Régions SAS
![]() Sofimac Régions SAS Investment ManagersFinance Sofimac Régions SAS is a Private Equity/Venture Capital firm, a subsidiary of Sofimac Investment Managers SAS founded in 1978. Sofimac Régions is headquartered in Clermont-Ferrand. | Miembro del Comité de Inversión | 22/06/2010 | - |
Inversor de Capital Privado | 01/10/1999 | - |
Historial de carrera de Jean-Pierre Bouiller
Antiguos cargos conocidos de Jean-Pierre Bouiller.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Imaxio SA
![]() Imaxio SA Medical SpecialtiesHealth Technology Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France. | Director/Miembro de la Junta | 18/01/2011 | - |
Estadísticas
Internacional
Francia | 3 |
Operativa
Investment Committee Member | 1 |
Private Equity Investor | 1 |
Director/Board Member | 1 |
Sectorial
Finance | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Sofimac Régions SAS
![]() Sofimac Régions SAS Investment ManagersFinance Sofimac Régions SAS is a Private Equity/Venture Capital firm, a subsidiary of Sofimac Investment Managers SAS founded in 1978. Sofimac Régions is headquartered in Clermont-Ferrand. | Finance |
Imaxio SA
![]() Imaxio SA Medical SpecialtiesHealth Technology Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France. | Health Technology |
- Bolsa de valores
- Insiders
- Jean-Pierre Bouiller
- Experiencia